Over two dozen cases of the rare blood disorder thrombocytopenia have been reported in people who have received COVID vaccines in the U.S. However, a link between COVID vaccines and the disease that ...

An experimental monoclonal antibody called ianalumab had promising results for more than half of patients with primary immune thrombocytopenia enrolled in a phase 3 trial, according to data published ...

X. Long Zheng, MD, PhD, gives an overview on acquired thrombotic thrombocytopenic purpura including prevalence and the typical patient presentation. X. Long Zheng, MD, PhD: What is acquired TTP? TTP ...

A recent study reveals thrombocytopenia as a significant prognostic factor in low-risk MDS, impacting survival and treatment ...

Lupus may cause you to experience low platelet counts. This could be a direct result of the disease or due to some lupus medications. Severe cases can be life threatening, but most cases are mild and ...

ITP can be chronic, but it may also go away on its own if it’s acute. Treatments may vary, depending on the type you have. Examples include splenectomy, corticosteroids, and platelet growth factors.

Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...

It is essential to maintain adequate platelet levels to ensure that blood clotting in the body is running properly. So, how ...

Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,262% of patients treated with ...

Platelets (also called thrombocytes) are small blood cell fragments made by your bone marrow. They help form blood clots to stop you from bleeding when you've been injured. Platelets are small cell ...